Clinical Trial Update: Host Genome Methylation: a Screening Tool in Anal Cancer Detection [NA]

View source ↗

Summary

A recruiting clinical trial from Assistance Publique - Hôpitaux de Paris is evaluating host genome methylation as a screening tool for detecting anal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Anal Cancer | NA | Status: RECRUITING